Olanzapine-induced hair loss [10]

Canadian Journal of Psychiatry

Volumn 47, Issue 9, 2002, Pages 891-892

  Leung, Marianna ^a   Wrixon, Katherine ^a   Remick, Ronald A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; FLUPENTIXOL; HALOPERIDOL; LITHIUM; OLANZAPINE; SELENIUM; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; ZINC;

ADULT; CASE REPORT; CLINICAL FEATURE; DRUG INDUCED DISEASE; EROTOMANIA; FEMALE; HAIR LOSS; HUMAN; LETTER; PATIENT COMPLIANCE; PERSECUTORY DELUSION; RISK FACTOR; SYMPTOM;

EID: 0036861153     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674370204700925     Document Type: Letter

References (8)

1. Provincial Toxicology Laboratory. Riverview Hospital. Coquitlam (BC).
2. Mercke Y, Sheng H, Khan T, Lippmann S. Hair loss in psychopharmacology. Ann Clin Psychiatry 2000;12:35-42.
3. Gautam M. Alopecia due to psychotropic medications. Ann Pharmacother 1999;33:63-7.
4. Parameshwar E. Hair loss associated with fluvoxamine use. Am J Psychiatry 1996;153:581-2.
5. Zalsman G, Sever J, Munitz H. Hair loss associated with paroxetine treatment: A case report. Clin Neuropharmacol 1999;22:246-7.
6. Ruiz-Doblado S, Carrizosa A, Garcia-Hernandez MJ, Rodriguez-Pichardo A. Selective serotonin reuptake inhibitor (SSRIs) and alopecia areata. Int J Derm 1998;38:798-9.
7. Gupta S, Gilroy WR. Hair loss associated with nefazodone. J Fam Pract 1997;44:20-1.
8. Kubota T, Ishikura T, Jibiki I. Alopecia areata associated with haloperidol. Jpn J Psychiatry Neurol 1994;48:579-81.